Neoglycorandomization and digitoxin analogs

Details for Australian Patent Application No. 2005258280 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Langenhan, Joseph M.; Thorson, Jon S.

Agent Shelston IP

Pub. Number AU-B-2005258280

PCT Pub. Number WO2006/002381

Priority 60/521,721 24.06.04 US

Filing date 24 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 10 December 2009

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002381 Priority application(s): WO2006/002381

22 March 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Langenham, Joseph M. to Langenhan, Joseph M.

10 December 2009 Application Accepted

  Published as AU-B-2005258280

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258281-Arrays with cleavable linkers

2005258276-Optimized dosing with anti-CD4 antibodies for tolerance induction in primates